Revolution Medicines, Inc. Common Stock (RVMD) Stock Price, Quote & AI Analysis

Live RVMD stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Revolution Medicines, Inc. Common Stock.

TradeVae provides AI-driven analysis and real-time market intelligence for Revolution Medicines, Inc. Common Stock (RVMD), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

RVMD
Revolution Medicines, Inc. Common Stock
real-time
$0.00 +0.00 (+0.00%)
Open
96.520000
High
97.176000
Low
95.920000
Volume
86,697
VWAP
-
Market Cap
$18,815,816,620.65
52W Range
$29.17 - $124.49
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Feb 24, 2026 Q4
After Hours
EPS Estimate: $-1.6161
Revenue Estimate: $3,972,002.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Revolution Medicines, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Revolution Medicines, Inc. Common Stock Overview

Company information

Company Overview

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Company Details
Market Cap
$18.54B
Shares Outstanding
193,320,000
Weighted Shares Outstanding
193,319,805
CEO
Mark A. Goldsmith
Address
700 SAGINAW DR, REDWOOD CITY, CA, 94063
Employees
809
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Revolution Medicines, Inc. Common Stock Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...